We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STX icon
101
Seagate
STX
$190B
$22.8M 0.31%
23,637
+1,990
+9% +$1.52M
MSI icon
102
Motorola Solutions
MSI
$80.3B
$22.4M 0.3%
54,014
+1,433
+3% +$600K
DNTH icon
103
Dianthus Therapeutics
DNTH
$5.99B
$22M 0.29%
225,261
– –
MLM icon
104
Martin Marietta Materials
MLM
$37.6B
$21.6M 0.29%
37,385
+34,477
+1,186% +$20.4M
WEC icon
105
WEC Energy
WEC
$34.5B
$21.1M 0.28%
179,606
-29,466
-14% -$3.36M
GKOS icon
106
Glaukos
GKOS
$10.6B
$21M 0.28%
150,036
– –
CRDO icon
107
Credo Technology Group
CRDO
$43.8B
$20.9M 0.28%
77,348
+74,650
+2,767% +$14.7M
SION
108
Sionna Therapeutics
SION
$269M
$20.9M 0.28%
474,981
-170,549
-26% -$6.82M
MU icon
109
Micron Technology
MU
$1.05T
$20.9M 0.28%
18,164
+312
+2% +$234K
AVGO icon
110
Broadcom
AVGO
$1.75T
$20.8M 0.28%
55,303
-3,814
-6% -$1.53M
CELC icon
111
Celcuity
CELC
$4.33B
$20.6M 0.28%
196,770
-47,129
-19% -$5.44M
AJG icon
112
Arthur J. Gallagher & Co
AJG
$68.8B
$19.9M 0.27%
86,769
+3,099
+4% +$658K
STRO icon
113
Sutro Biopharma
STRO
$341M
$19.4M 0.26%
585,262
-130,045
-18% -$4.05M
CEG icon
114
Constellation Energy
CEG
$98.5B
$19.3M 0.26%
77,125
-983
-1% -$277K
PRVA icon
115
Privia Health
PRVA
$2.66B
$19M 0.25%
737,694
– –
HTFL
116
Heartflow Inc
HTFL
$4.16B
$18.7M 0.25%
636,942
-120,014
-16% -$3.6M
WGS icon
117
GeneDx Holdings
WGS
$2.6B
$18.5M 0.25%
269,542
-189,473
-41% -$10.8M
SYRE icon
118
Spyre Therapeutics
SYRE
$7.99B
$17.9M 0.24%
+201,616
New +$14.7M
EYPT icon
119
EyePoint Inc
EYPT
$385M
$17.8M 0.24%
1,245,583
– –
TSM icon
120
TSMC
TSM
$2.18T
$17.5M 0.23%
37,413
-2,964
-7% -$1.2M
RBRK icon
121
Rubrik
RBRK
$19.4B
$17.4M 0.23%
216,431
+204,826
+1,765% +$12.9M
BKH icon
122
Black Hills Corp
BKH
$5.53B
$17.2M 0.23%
+230,351
New +$17M
AKTS
123
Aktis Oncology
AKTS
$1.44B
$16.3M 0.22%
507,000
– –
GRMN
124
Garmin
GRMN
$55.2B
$16.2M 0.22%
68,279
-2,626
-4% -$639K
EVMN
125
Evommune Inc
EVMN
$477M
$16.1M 0.21%
1,209,129
– –
3 4
5
6 7

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.